Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Statin/Choline Fenofibrate Combination vs Statin Monotherapy in Hypertriglyceridemia
NCT03874260Phase 4Unknown
- Sponsor
- Daewon Pharm
- Start
- Jul 2018
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of fenofibric acid in hypertriglyceridemia (2 arms), sponsored by Daewon Pharm. Primary endpoint: rate of change for Triglyceride based on baseline at 8 weeks. Status: unknown.
02
Drugs
fenofibric acid
03
Conditions
hypertriglyceridemia
Beyond the preview
Go deeper on NCT03874260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03874260.